- Current Status of Deceased Donor Liver Transplantation for Alcoholic Liver Disease in Korea in MELD Era
-
Joo DJ
- KMID: 2510770
- Korean J Gastroenterol.
- 2021 Jan;77(1):4-11.
- doi: 10.4166/kjg.2020.167
The organ allocation system should be fair and efficient to predict the prognosis of patients with end-stage organ failure. The liver allocation system in Korea was changed to the model... -
- CITED
-
- Close
- SHARE
-
- Close
- Bone Marrow Chimerism Detection Using Next Generation Sequencing Based on Single Nucleotide Polymorphisms Following Liver Transplantation: Comparison With Short Tandem Repeat-PCR
-
Kim J, Hwang IS, Kim HS, Joo DJ, Hong KR, Choi JR
- KMID: 2373506
- Ann Lab Med.
- 2016 Jan;36(1):82-84.
- doi: 10.3343/alm.2016.36.1.82
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Verruca Eradication Following Conversion to Sirolimus in a Renal Transplant Recipient after Longstanding Cyclosporine A Treatment
-
Joo DJ, Kim SH, Huh KH, Kim YS
- KMID: 2003537
- J Korean Soc Transplant.
- 2012 Sep;26(3):207-209.
- doi: 10.4285/jkstn.2012.26.3.207
We present the case of a 50-year-old male kidney transplant recipient whose verruca skin warts completely disappeared after conversion of immunosuppressive treatment from cyclosporine A to sirolimus. Before conversion, the... -
- CITED
-
- Close
- SHARE
-
- Close
- Second hand allotransplantation experience after the revised transplantation law: 5-month follow-up
-
Kim Y, Hong JW, Lee SJ, Kim SH, Jwa SJ, Joo OY, Mo YW, Suh YC, Choi YR, Joo DJ
- KMID: 2535664
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S148.
- doi: 10.4285/ATW2022.F-2663
Background: Hand transplantation for upper extremity amputation provides a unique treatment that restores form and function. In January 2021, the first hand allotransplantation since legalization was successfully performed. Based on... -
- CITED
-
- Close
- SHARE
-
- Close
- Graft-versus-host disease after simultaneous pancreas-kidney transplantation
-
Lee J, Kim MS, Huh KH, Joo DJ, Lee JG, Kim SI
- KMID: 2503784
- Korean J Transplant.
- 2020 Mar;34(1):62-65.
- doi: 10.4285/kjt.2020.34.1.62
Graft-versus-host disease (GVHD) is rare complication after simultaneous pancreas-kidney transplantation (SPK). Here, we present a rare case of GVHD that developed in a SPK recipient. A 38-year-old female patient with... -
- CITED
-
- Close
- SHARE
-
- Close
- Antiplatelet drugs on the recurrence of hepatocellular carcinoma after liver transplantation
-
Kim DG, Choi MC, Min EK, Lee JG, Joo DJ, Kim MS
- KMID: 2535668
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S152.
- doi: 10.4285/ATW2022.F-2717
Background: Previous studies reported suppressive effects of antiplatelet agents on hepatocellular carcinoma (HCC); however, this has never been assessed in patients who underwent liver transplantation (LT). Methods: This retrospective observational study... -
- CITED
-
- Close
- SHARE
-
- Close
- Curative liver transplantation after lung resection for advanced hepatocellular carcinoma with lung metastasis and inferior vena cava tumor thrombosis: a case report
-
Joo DJ, Kim DY, Seong J, Kim HJ, Lee JG, Han DH, Choi GH, Kim MS, Choi JS, Kim SI
- KMID: 2520906
- J Liver Cancer.
- 2021 Sep;21(2):181-186.
- doi: 10.17998/jlc.2021.09.08
Hepatocellular carcinoma (HCC) with distant metastasis is an absolute contraindication for liver transplantation (LT). However, it is still unclear whether LT is feasible or acceptable in such patients, albeit after... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma
-
Kang I, Joo DJ
- KMID: 2509306
- Korean J Transplant.
- 2020 Dec;34(Supple 1):S116.
- doi: 10.4285/ATW2020.OP-1033
Background: The objective of this study was to investigate whether everolimus (EVR) use affects long-term survival after liver transplantation (LT) in patients with hepatocellular carcinoma (HCC). Methods: Data from 303 consecutive... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical association between tacrolimus intra-patient variability and liver transplantation outcomes in patients with and without hepatocellular carcinoma
-
Kim HJ, Lee JG, Joo DJ, Kim MS, Lee J
- KMID: 2535242
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S362.
- doi: 10.4285/ATW2022.F-5022
Tacrolimus is the mainstay of immunosuppression in liver transplantation to prevent rejection. However, the clinical use of tacrolimus is complicated by its narrow therapeutic window and significant intra-patient variability (IPV).... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics of Focal Segmental Glomerulosclerosis Recurrence after Adult Renal Transplantation
-
Joo DJ, Lee JJ, Lee BM, Kim MS, Huh KH, Kim SJ, Kim SI, Kim YS
- KMID: 1457128
- J Korean Soc Transplant.
- 2010 Jun;24(2):87-92.
- doi: 10.4285/jkstn.2010.24.2.87
BACKGROUND: Recurrence of focal segmental glomerulosclerosis (FSGS) after kidney transplantation is a frequent and still unpredictable complication. Moreover, risk factors for recurrence have not yet been clearly identified. METHODS: We enrolled... -
- CITED
-
- Close
- SHARE
-
- Close
- Most Transmitted Glomerular Lesions in a Zero-Hour Biopsy of Allograft Kidney Have No Clinical Significance
-
Lim BJ, Joo DJ, Kim YS, Jeong HJ
- KMID: 2003532
- J Korean Soc Transplant.
- 2012 Sep;26(3):174-177.
- doi: 10.4285/jkstn.2012.26.3.174
BACKGROUND: The clinical significance of glomerular lesions detected in zero-hour renal allograft biopsies have yet to be fully examined. METHODS: We retrospectively reviewed 229 zero-hour renal allograft biopsies, and investigated the... -
- CITED
-
- Close
- SHARE
-
- Close
- Organ procurement in a deceased donor
-
Hwang HP, Kim JM, Shin S, Ahn HJ, Lee S, Joo DJ, Han SY, Haam SJ, Hwang JK, Yu HC
- KMID: 2507153
- Korean J Transplant.
- 2020 Sep;34(3):134-150.
- doi: 10.4285/kjt.2020.34.3.134
With the increasing demand for organ transplantation, organ procurement from a deceased donor is an essential step for deceased donor organ transplantation. A proper surgical technique for the procurement of... -
- CITED
-
- Close
- SHARE
-
- Close
- The feasibility of organ transplantation during the COVID-19 outbreak: experiences from South Korea
-
Lee J, Kim EJ, Ihn K, Lee JG, Joo DJ, Kim MS, Kim SI, Kim YS, Huh KH
- KMID: 2510264
- Korean J Transplant.
- 2020 Dec;34(4):257-264.
- doi: 10.4285/kjt.20.0048
Background: The coronavirus disease 2019 (COVID-19) has forced healthcare systems to reduce transplant activities in order to preserve resources and minimize the risk of nosocomial transmission. Although transplantation societies around... -
- CITED
-
- Close
- SHARE
-
- Close
- Differential impact of tacrolimus intra-patient variability on liver transplant outcomes in patients with and without hepatocellular carcinoma
-
Kim HJ, Lee JG, Joo DJ, Kim MS, Kim SI, Lee J
- KMID: 2521192
- Korean J Transplant.
- 2021 Oct;35(Supple 1):S20.
- doi: 10.4285/ATW2021.OP-1273
Background: The recurrence rate for hepatocellular carcinoma (HCC) after liver transplant is high as 15%–20% despite a careful selection of candidates. Although immunosuppression plays an important role in post-transplant HCC... -
- CITED
-
- Close
- SHARE
-
- Close
- Predicted Impact of the Model for End-Stage Liver Disease 3.0 in a Region Suffering Severe Organ Shortage
-
Kim DG, Yim SH, Min EK, Choi MC, Lee JG, Kim MS, Joo DJ
- KMID: 2545552
- J Korean Med Sci.
- 2023 Sep;38(35):e274.
- doi: 10.3346/jkms.2023.38.e274
Background The model for end-stage liver disease 3.0 (MELD3.0) is expected to address the flaws of the current allocation system for deceased donor liver transplantation (DDLT). We aimed to validate MELD3.0... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of cumulative exposure to tacrolimus on the recurrence of hepatocellular carcinoma after liver transplantation
-
Kim DG, Lee JG, Joo DJ, Kim MS
- KMID: 2535672
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S156.
- doi: 10.4285/ATW2022.F-2755
Background: Previous studies reported that maintaining at lower trough level of tacrolimus could reduce the recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT); however, this has never been assessed... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical impact of myosteatosis in liver transplant recipients
-
Lee J, Koh HH, Min E, Yim SH, Choi M, Kim DG, Lee JG, Joo DJ
- KMID: 2535529
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S302.
- doi: 10.4285/ATW2022.F-4418
Background: Myosteatosis, excessive intramuscular fat disposition, is common in patients with chronic liver disease and is associated with increased morbidity and mortality. We investigated the effects of pretransplant myosteatosis on... -
- CITED
-
- Close
- SHARE
-
- Close
- Single Center Experience of Biliary Reconstruction in Living Donor Liver Transplantation: Duct-to-Duct Anastomosis
-
Nam JH, Yang SJ, Lee JG, Joo DJ, Han DH, Choi GH, Choi JS
- KMID: 2202622
- J Korean Soc Transplant.
- 2016 Mar;30(1):6-12.
- doi: 10.4285/jkstn.2016.30.1.6
BACKGROUND: Duct-to-duct anastomosis is the most common biliary reconstruction method in living donor liver transplantation. However, biliary complications can frequently occur. The objective of this study was to examine biliary... -
- CITED
-
- Close
- SHARE
-
- Close
- Antitumor Effect of Low-Dose of Rapamycin in a Transgenic Mouse Model of Liver Cancer
-
Lee HS, Kim JY, Ro SW, Kim MS, Kim H, Joo DJ
- KMID: 2536371
- Yonsei Med J.
- 2022 Nov;63(11):1007-1015.
- doi: 10.3349/ymj.2022.0247
Purpose: We investigate whether low-dose rapamycin is effective in preventing hepatocellular carcinoma (HCC) growth and treating HCC after tumor development in transgenic mice. Materials and Methods: We established transgenic mice with... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of tacrolimus intra-patient variability on kidney transplant outcomes according to immunologic risk
-
Kim EJ, Lee J, Kim SJ, Lee JG, Kim BS, Joo DJ, Huh KH, Kim MS, Kim SI, Kim YS
- KMID: 2509177
- Korean J Transplant.
- 2020 Dec;34(Supple 1):S44.
- doi: 10.4285/ATW2020.OR-1255
Background: High intra-patient variability (IPV) of tacrolimus trough concentrations is increasingly recognized as a predictor of poor long-term outcomes in kidney transplant recipients. However, there is a lack of information... -
- CITED
-
- Close
- SHARE
-
- Close
